EP3999069
SYNERGISTIC EFFECT OF EYP001 AND PEGYLATED IFN-ALPHA FOR THE TREATMENT OF HBV INFECTION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.7.2020EP published:
11.10.2023EP application number:
20740022.7
EPO information:
European Patent Register
Max expiry date:
16.7.2040
Title in English:
SYNERGISTIC EFFECT OF EYP001 AND PEGYLATED IFN-ALPHA FOR THE TREATMENT OF HBV INFECTIONLanguage of the patent:
English
Timeline
Today
17.7.2020EP application
11.10.2023EP Publication
Owner
Name:
ENYO PharmaAddress:
60 avenue Rockefeller Bioserra 1 Bâtiment B, 69008 Lyon, FR
Inventor
Name:
VONDERSCHER, JackyAddress:
81600 SENOUILLAC, FR
Name:
ROY, EliseAddress:
1012 LAUSANNE, CH
Name:
DARTEIL, RaphaëlAddress:
69006 LYON, FR
Name:
SCALFARO, PietroAddress:
3984 FIESCH, CH
Priority
Number:
19186941Date:
18.7.2019Country:
EP
Classification
Categories:
A61K 31/496, A61K 38/21, A61P 31/20, A61K 31/52